Kaisa Health Group Holdings Limited is an investment holding company principally engaged in the research, development, manufacture, and sale of dental prosthetics, as well as the provision of healthcare and wellness services. The company operates primarily through two business segments: Dental Prosthetics and Healthcare Business. Its Dental Prosthetics division designs and manufactures custom dental restorations and medical devices, including porcelain-fused-to-metal (PFM) crowns and bridges; all-ceramic and full-contour zirconia restorations; partial and complete removable dentures; implant-supported prosthetics and custom abutments; orthodontic appliances and clear aligners; computer-aided design and computer-aided manufacturing (CAD/CAM) dental products; and pediatric oral care appliances. Its Healthcare Business division offers aesthetic medicine services; physical examination and health screening programs; chronic disease management and rehabilitation services; healthcare facility operation and management; and the trading and distribution of medical devices, healthcare equipment, and wellness supplies. The company serves dental clinics, hospitals, dental laboratories, medical institutions, and individual consumers across mainland China, Hong Kong, North America, Europe, and other international markets. Founded in 1989 and headquartered in Hong Kong, Kaisa Health Group Holdings Limited operates as a key healthcare subsidiary of Kaisa Group Holdings Limited. In recent developments, the company executed a capital reorganization involving a share consolidation to optimize its capital structure and trading liquidity on the Hong Kong Stock Exchange. Furthermore, the company has accelerated its transition toward digital dentistry by integrating 3D printing and digital impression scanning workflows, upgraded its dental manufacturing facilities to meet overseas export demand, rationalized its aesthetic medical and rehabilitation service footprint within the Guangdong-Hong Kong-Macao Greater Bay Area, and established strategic supply partnerships to broaden its healthcare product offerings.